EXACT Therapeutics AS (OSL:EXTX)

Norway flag Norway · Delayed Price · Currency is NOK
1.790
-0.010 (-0.56%)
At close: Oct 21, 2025
-0.56%
Market Cap126.53M
Revenue (ttm)n/a
Net Income (ttm)-72.20M
Shares Out63.26M
EPS (ttm)-1.44
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume55,163
Average Volume54,122
Open1.800
Previous Close1.800
Day's Range1.770 - 1.800
52-Week Range1.570 - 6.050
Beta0.13
RSI40.65
Earnings DateDec 25, 2025

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 12
Stock Exchange Oslo Børs
Ticker Symbol EXTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.